POC

Singapore Emerges as IVD Leader in APAC Region, finds Kalorama Information

Retrieved on: 
Monday, December 5, 2022

ARLINGTON, Va., Dec. 5, 2022 An aging and higher-income regionally population are the main factors boosting Singapore as an in vitro diagnostic (IVD) market, according to Kalorama Information.

Key Points: 
  • ARLINGTON, Va., Dec. 5, 2022 An aging and higher-income regionally population are the main factors boosting Singapore as an in vitro diagnostic (IVD) market, according to Kalorama Information.
  • The medical market researcher recently published a report on the region, In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022 .
  • The firm found that Singapore is one of the most prosperous nations in the APAC region and that extends to its in vitro diagnostics market.
  • Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals.

PLVision Announces SONiC Core Initiative to Extend Community SONiC for New Markets

Retrieved on: 
Friday, December 2, 2022

PLVision, a custom software product development company focused on open networking systems, announced today the launch of its SONiC Core initiative aimed at extending the reach of Community SONiC to drive its adoption in new, demanding markets.

Key Points: 
  • PLVision, a custom software product development company focused on open networking systems, announced today the launch of its SONiC Core initiative aimed at extending the reach of Community SONiC to drive its adoption in new, demanding markets.
  • However, with the functionality available today, Community SONiC is not yet ready to fulfill all the specific requirements of the new markets.
  • The initiative also includes the gradual development of additional SONiC features to support new use cases and further upstreaming to Community SONiC to expand its capabilities.
  • PLVision is committed to bringing Community SONiC to the next level of user experience and lowering barriers to mass consumption.

GRACELIGHT HOME HEALTH SELECTS COMPLIA HEALTH'S CONTINULINK EMR

Retrieved on: 
Thursday, December 1, 2022

SCHAUMBURG, Ill., Dec. 1, 2022 /PRNewswire/ -- Complia Health, a leading home health and hospice technology provider, announced today their selection by Gracelight Home Health, a provider of skilled medical services for elderly, chronically ill, disabled, and recuperating patients, to automate the agency through their ContinuLink platform.

Key Points: 
  • Family-Owned Home Health Provider Enlists Complia Health to Automate Processes, Create Efficiencies and Optimize Quality of Care
    SCHAUMBURG, Ill., Dec. 1, 2022 /PRNewswire/ -- Complia Health, a leading home health and hospice technology provider, announced today their selection by Gracelight Home Health, a provider of skilled medical services for elderly, chronically ill, disabled, and recuperating patients, to automate the agency through their ContinuLink platform.
  • "During our due diligence process we narrowed down our selection to six EMR solution providers and Complia Health emerged as the superior solution," explained CEO Bryan Chavarria.
  • Their EMMA chatbot immediately differentiated Complia Health from other providers.
  • Complia Health technology solutions are designed to improve clinical outcomes and clinician and consumer experiences.

Lucas Ager Named Lead for INCATech's Acquisition and Financial Services (AFS) Practice Area.

Retrieved on: 
Thursday, December 1, 2022

RESTON, Va., Dec. 1, 2022  /PRNewswire-PRWeb/ -- To most effectively serve our customers with unique challenges such as complex regulations, limited personnel, fiscal constraints, and increasing inquiries, INCATech is establishing an Acquisition and Financial Services (AFS) practice, led by Lucas Ager. As Practice Lead, Ager will spearhead INCATech's AFS support to include:

Key Points: 
  • To most effectively serve our customers with unique challenges such as complex regulations, limited personnel, fiscal constraints, and increasing inquiries, INCATech is establishing an Acquisition and Financial Services (AFS) practice, led by Lucas Ager.
  • RESTON, Va., Dec. 1, 2022 /PRNewswire-PRWeb/ -- To most effectively serve our customers with unique challenges such as complex regulations, limited personnel, fiscal constraints, and increasing inquiries, INCATech is establishing an Acquisition and Financial Services (AFS) practice, led by Lucas Ager.
  • Ager serves as the primary Point of Contract (POC) for federal customers to identify needs and ensure that INCATech provides excellent services.
  • Our expert teams apply Agile methodologies and use state-of-the-art products to achieve your mission goals and deliver breakthrough results: https://incatech-corp.com

Popular Science Announces The 100 Best Innovations of 2022

Retrieved on: 
Wednesday, November 30, 2022

NEW YORK, Nov. 30, 2022 /PRNewswire/ -- Today, Popular Science announced the 2022 " Best of What's New " Award winners featuring the most innovative products and technology of the year.

Key Points: 
  • NEW YORK, Nov. 30, 2022 /PRNewswire/ -- Today, Popular Science announced the 2022 " Best of What's New " Award winners featuring the most innovative products and technology of the year.
  • "The 'Best of What's New' Awards are our way of celebrating the most exciting and groundbreaking innovations of the year.
  • These awards highlight the revolutionary inventions that are helping to improve our daily lives, our society, and our planet," says Rob Verger, Technology Editor, Popular Science.
  • Every year since 1988, the editors of Popular Science have reviewed thousands of products in search of the top 100 innovationsbreakthrough products and technologies that represent significant advancements in their categories.

Cardiac Troponin Diagnostics Market Growth Boosted by High-sensitivity Point-of-care Testing

Retrieved on: 
Wednesday, November 30, 2022

SAN ANTONIO, Nov. 30, 2022 /PRNewswire/ -- The global demand for cardiac troponin (cTn) diagnostics biomarkers is increasing as more patients with cardiac complaints are visiting emergency departments (EDs), according to Frost & Sullivan's recent analysis of the cTn diagnostics market. The sector is driven by hospitals and clinical laboratories adopting high-sensitivity (hs)-cTn assays, which can detect troponin in lower concentrations and significantly shorten the timeline for myocardial infarction (MI) detection. The global market for cTn diagnostics is expected to reach $2.28 billion by 2025, up from $2.07 billion in 2021, representing a 2.4% compound annual growth rate.

Key Points: 
  • SAN ANTONIO, Nov. 30, 2022 /PRNewswire/ -- The global demand for cardiac troponin (cTn) diagnostics biomarkers is increasing as more patients with cardiac complaints are visiting emergency departments (EDs), according to Frost & Sullivan's recent analysis of the cTn diagnostics market.
  • The global market for cTn diagnostics is expected to reach $2.28 billion by 2025, up from $2.07 billion in 2021, representing a 2.4% compound annual growth rate.
  • Soundankar added: "Point-of-care testing (POCT) is rapidly gaining traction globally and reduces turnaround time and the length of stay in the ED.
  • For over six decades, Frost & Sullivan has helped build sustainable growth strategies for Fortune 1000 companies, governments, and investors.

Cardiac Troponin Diagnostics Market Growth Boosted by High-sensitivity Point-of-care Testing

Retrieved on: 
Wednesday, November 30, 2022

SAN ANTONIO, Nov. 30, 2022 /PRNewswire/ -- The global demand for cardiac troponin (cTn) diagnostics biomarkers is increasing as more patients with cardiac complaints are visiting emergency departments (EDs), according to Frost & Sullivan's recent analysis of the cTn diagnostics market. The sector is driven by hospitals and clinical laboratories adopting high-sensitivity (hs)-cTn assays, which can detect troponin in lower concentrations and significantly shorten the timeline for myocardial infarction (MI) detection. The global market for cTn diagnostics is expected to reach $2.28 billion by 2025, up from $2.07 billion in 2021, representing a 2.4% compound annual growth rate.

Key Points: 
  • SAN ANTONIO, Nov. 30, 2022 /PRNewswire/ -- The global demand for cardiac troponin (cTn) diagnostics biomarkers is increasing as more patients with cardiac complaints are visiting emergency departments (EDs), according to Frost & Sullivan's recent analysis of the cTn diagnostics market.
  • The global market for cTn diagnostics is expected to reach $2.28 billion by 2025, up from $2.07 billion in 2021, representing a 2.4% compound annual growth rate.
  • Soundankar added: "Point-of-care testing (POCT) is rapidly gaining traction globally and reduces turnaround time and the length of stay in the ED.
  • For over six decades, Frost & Sullivan has helped build sustainable growth strategies for Fortune 1000 companies, governments, and investors.

Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy

Retrieved on: 
Tuesday, November 29, 2022

John Hardesky, Chief Commercial Officer of Nanomix, stated, Gepa has significant experience in this increasingly complex and important segment of critical infections, sepsis, and antibiotic stewardship.

Key Points: 
  • John Hardesky, Chief Commercial Officer of Nanomix, stated, Gepa has significant experience in this increasingly complex and important segment of critical infections, sepsis, and antibiotic stewardship.
  • We are excited to support and align with Gepa on an ambitious execution plan to bring our technology to a competitive market like Italy.
  • Riccardo Figus, Business Manager of Gepa, commented, The GEPA team is very excited to develop the Italian market for the new eLab, a true Point of Care device.
  • The agreement with Nanomix enables us to offer our customers an innovative solution for the fight against sepsis.

Exposing Racism and Discrimination in Marin County; Schools and Community

Retrieved on: 
Monday, November 28, 2022

MARIN COUNTY, Calif. , Nov. 28, 2022  /PRNewswire-PRWeb/ -- September 2022 - protests sparked in Marin County. Heart Blaster was tagged in multiple posts on Instagram, and we were sent a flyer and body cam footage via DM that was aired on ABC 7 Bay Area News by a resident in the Canal Community. The flyer read #justiceformateo and the video footage was graphic and disturbing. The body cam footage showed Mateo being slammed to the ground and punched in the face by Officer Brandon Nail, with Officer Daisy Mazariegos standing nearby.

Key Points: 
  • Heart Blaster Incorporated is bringing to light the racism and discrimination happening in the community of Marin County.
  • We learned from community members that Mateo, a local gardener from the Canal Community, was enjoying a beer behind a local restaurant.
  • We have learned much about how this community functions while organizing with community members for Mateo and since then.
  • Nonprofit organizations are at odd ends with the community, and we have collected many stories of trauma, discrimination, and racism.

Veris Wealth Partners Releases 2022 Impact Report

Retrieved on: 
Monday, November 28, 2022

Veris Wealth Partners , a B Corp certified impact wealth management firm founded in 2007, has released its 2022 Impact Report.

Key Points: 
  • Veris Wealth Partners , a B Corp certified impact wealth management firm founded in 2007, has released its 2022 Impact Report.
  • Founded in 2007, Veris Wealth Partners is one of the oldest and most experienced impact wealth management firms.
  • The impact metrics presented in the Impact Report are compiled based on information reported by managers and funds utilized by Veris and are estimated and unaudited.
  • 1 Veris 2022 Impact Report, IRIS Metric PI5842, reported by 10 alternative strategies and 3 public equity strategies
    2 Veris 2022 Impact Report, IRIS Metric PI5965, reported by 13 alternative strategies and 6 public fixed income strategies
    3 Veris 2022 Impact Report, IRIS Metric OI6912 and PI6796, reported by 15 alternative strategies and 5 public fixed income strategies
    4 Veris 2022 Impact Report, Reported by 11 and 9 alternative strategies, respectively
    View source version on businesswire.com: https://www.businesswire.com/news/home/20221128005169/en/